TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novel Medic AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
27,553
|
34,426
|
42,697 |
| Financial expenses |
0
|
0
|
36 |
| Earnings before taxes |
8,652
|
9,594
|
26,088 |
| EBITDA |
11,221
|
11,156
|
26,823 |
| Total assets |
28,391
|
41,720
|
37,842 |
| Current assets |
19,190
|
32,990
|
30,402 |
| Current liabilities |
3,536
|
3,684
|
5,109 |
| Equity capital |
22,985
|
36,166
|
31,314 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
9
|
13
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.0%
|
86.7%
|
82.7% |
| Turnover per employee |
3,061
|
2,648
|
3,050 |
| Profit as a percentage of turnover |
31.4%
|
27.9%
|
61.1% |
| Return on assets (ROA) |
30.5%
|
23.0%
|
69.0% |
| Current ratio |
542.7%
|
895.5%
|
595.1% |
| Return on equity (ROE) |
37.6%
|
26.5%
|
83.3% |
| Change turnover |
-6,873
|
-8,271
|
10,639 |
| Change turnover % |
-20%
|
-19%
|
33% |
| Chg. No. of employees |
-4
|
-1
|
4 |
| Chg. No. of employees % |
-31%
|
-7%
|
40% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.